Skip to content Skip to Search
Skip navigation

Kuwait’s pharmaceutical plan may need a shot in the arm

Kuwait faced a shortage of 7.5% of medicines in 2022 and it is now trying to improve its domestic pharmaceutical sector Pixabay/Hosny Salah
Kuwait faced a shortage of 7.5% of medicines in 2022 and it is now trying to improve its domestic pharmaceutical sector
  • Plans to improve pharma sector
  • Medicine shortages fairly common
  • GCC neighbours’ sectors stronger

Kuwait will continue to lag behind its GCC neighbours in attracting investment into its pharmaceutical sector despite new government measures, say experts.

The Ministry of Health announced plans last month to set up warehouses across health districts, adding new facilities to improve medication storage and delivery.

It said it is also developing a guide for managing risks and crises in the pharmaceutical and medical supply sectors, prioritising regional purchases and local contracts to maintain supply stability during emergencies.

Analysts at BMI said that although the plan is likely to strengthen Kuwait’s pharmaceutical resilience and prevent medicine shortages, ongoing political instability will continue to deter investments in the sector. 

There was a shortage of 210 medicines in 2022, representing 7.5 percent of all medications listed in Kuwait. 

Health minister Ahmed Al-Awadi’s new strategy aims to address sector shortcomings, including inadequate storage capacity and insufficient monitoring of drug consumption and demand. 

BMI said Kuwait is the latest government in the Middle East to identify the importance of enhancing its domestic pharmaceutical industry and working to reduce import dependency for essential medicines. 

“However, Kuwait trails far behind neighbouring markets in the development of its pharmaceutical sector,” analysts noted. 

In 2023, the Kuwait Direct Investment Promotion Authority reported that the Kuwait Saudi Pharmaceutical Industries Company is the sole local manufacturer. It has a limited portfolio of generic painkillers and antibiotics. 

In contrast, Saudi Arabia and the UAE have several multinational pharmaceutical companies partnering with local drug makers, enhancing domestic manufacturing infrastructure and expertise. 

Because of its underdeveloped pharmaceutical industry, Kuwait is one of the Mena markets most reliant on imported pharmaceuticals, with imports accounting for 90 percent of the market, BMI analysts calculated.

“We foresee Kuwait’s pharmaceutical market size to grow at a much slower rate compared to the rest of the Mena and GCC markets,” they added. 

By 2027, BMI forecasts Kuwait’s pharmaceutical industry to reach $2.9 billion, posting a five-year annual growth rate of 3.5 percent. 

In contrast, the GCC’s pharmaceutical industry will grow at 4.9 percent.

BMI also said that while the government has tried to boost non-oil sectors under the Kuwait Vision 2035 roadmap, diversification efforts have also lagged. 

Non-oil sectors including the pharma sector have been stifled by Kuwait’s inefficient political scene, it added. 

Bureaucratic hurdles and slow approval of projects has consistently limited the extent to which public funds are utilised, BMI said.

In October it was reported that Kuwait had used just 10 percent of its budgeted expenditure for public projects in the first half of the last fiscal year.

Kuwait also struggles to attract foreign direct investment, which totalled just $758 million in 2022. This compares with the UAE ($22.7 billion), Saudi Arabia ($7.8 billion) and Oman ($3.7 billion), according to the UN Conference on Trade and Development. 

“To boost the expansion of vital non-oil sectors, including the pharmaceutical industry, Kuwait must concentrate on establishing a more conducive environment for foreign direct investment and international industry collaborations,” BMI said.

Latest articles

Opec predicts global crude demand will rise by around 2 million barrels a day in both 2024 and 2025

Opec maintains stance on oil demand predictions

Opec has kept its global oil demand prediction unchanged for this year as the global economy showed resilience, surpassing initial projections in some instances. The oil producers block said in its monthly report on Tuesday that it believed global crude demand would increase by 2.2 million barrels per day (bpd) in 2024 and by 1.8 […]

Dnata staff load cargo into a plane at Cointrin Airport in Geneva. The company's expansion into Rome will need a €20 million investment

Dnata CEO confident of victory in Rome airport case

The Group CEO of Dnata, the Dubai-based global air and travel services provider, is “very confident” the company will soon begin operations in Rome. “We’re certainly planning to be operating this year,” Steve Allen told AGBI at a media event on Tuesday, referring to an appeal ruling on the decision to award ground-handling contracts due […]

Prime minister of Qatar Mohammed bin Abdulrahman Al-Thani said GCC states need to coordinate their efforts in sectors such as AI

Qatar calls for greater GCC cooperation as it diversifies economy

Qatar’s sovereign wealth fund will continue a policy of diversification, investing in Central Asia and Africa, but Gulf countries need to do more to unify their economic growth plans to face rising geopolitical risks, Qatar’s prime minister said on Tuesday.  “Our focus in terms of the sovereign wealth fund and investment continues following the strategy […]

Workers at a semiconductor plant in the Netherlands. Qatar's investment in France's Ardian comes as global demand for semiconductor chips is surging

QIA invests in French semiconductor fund Ardian

Qatar Investment Authority (QIA), the country’s sovereign wealth fund, has announced plans to make an anchor investment in Ardian Semiconductor, a new entity established by the French private equity firm Ardian.  The move underscores the Gulf state’s bet on the crucial role of semiconductors in powering digital and green transformations in key areas such as […]